Category Archives: Public Policy

Latest From Public Policy

State Legislator Profile: Washington State Rep. John McCoy

Washington State Rep. John McCoy (D-Tulalip)

If you ask most people to name a few things about the state of Washington, the word technology is likely to wind up somewhere in the mix. However, the birthplace of Microsoft and is also a biotech heavyweight. Washington contains one of the world’s largest life sciences clusters and is home to dozens of research institutes and some of the nation’s leading public research universities. The biotech industry in Washington employs tens of thousands Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

Biotechnology Patenting in Europe Event


BIO hosted a Biotechnology Patenting in Europe event last week here at BIO’s offices where attorneys from Carpmaels and Ransford addressed various issues of interest to U.S. biotechnology companies. Huw Halleybone discussed the relative challenges of patent harmonization in Europe quoting some reports that indicate that the cost of a European patent is 10 times the amount of the United States.  Most of this cost is mainly due to language translation requirements and renewal fees.  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Patent Reform Inches Closer to Becoming Law


Yesterday, Senate Majority Leader Harry Reid (D-NV) filed for cloture for The Leahy-Smith America Invents Act, H.R. 1249, bringing it one step closer to becoming law.  When the Senate reconvenes in September, patent reform will be at the top of the agenda. In his comments on the Congressional compromise on the debt ceiling, President Obama included patent reform in the list of action needed to stimulate the economy and create jobs: “Through patent reform, we Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , ,

University Licensing Survey 2010 – AUTM

AUTM is set to release their AUTM Licensing Activity Survey Summary: FY 2010 in the fall of this year for both the U.S. and Canada.  AUTM issued a AUTM 2010 survey highlights to wet the appetite. Highlights: -The number of startups formed increased 10.6%.  651 startup companies formed of which 498 had their primary place of business in the licensing institution’s home state. -Number of licenses/options executed to startups increased 14%.  4,284 licenses executed and Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Quandary for U.S. companies: Whom to bribe? (Washington Post)


From this Sunday’s Washington Post, David Hilzenrath lays out ambiguities of the Foreign Corrupt Practices Act. Scientific American’s Worldview 2011 report compares corruption among countries seeking to grow the biotech industry within their borders based on the 2010 Corruption Perceptions Index from Transparency International. Countries that ranked high in perceived corruption tended to rank lower in terms of overall innovation. In other words, as corruption increases, the nation’s business reputation sinks while those with a Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , ,